Evidence map›Paper›PMID 36925074›Full record

Trial reportInternational journal of radiation oncology, biology, physics2023

Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer.

Adam S Garden, Jonathan Harris, Avraham Eisbruch, K S Clifford Chao, William H Morrison, Paul M Harari, Todd Allen Swanson, Christopher U Jones, Sue S Yom, Sharon A Spencer and 7 more

Abstract readClinical Trial, Phase IIClinical Trial, Phase I
In one paragraph

Trial report in International journal of radiation oncology, biology, physics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Adam S GardenMD Anderson Cancer Center, Houston, Texas. Electronic address: agarden@mdanderson.org.
Jonathan HarrisNRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania; American College of Radiology, Reston, Virginia.
Avraham EisbruchUniversity of Michigan Medical Center, Ann Arbor, Michigan.
K S Clifford ChaoNYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York.
William H MorrisonMD Anderson Cancer Center, Houston, Texas.
Paul M HarariUniversity of Wisconsin Hospital and Clinics, Madison, Wisconsin.
Todd Allen SwansonUniversity of Texas Medical Branch, Galveston, Texas.
Christopher U JonesRadiological Associates of Sacramento, Sacramento, California.
Sue S YomUniversity of California, San Francisco, California.
Sharon A SpencerUniversity of Alabama at Birmingham Cancer Center, Birmingham, Alabama.
Rufus ScrimgerCross Cancer Institute, Edmonton, Alberta, Canada.
George ShenoudaDepartment of Oncology, McGill University, Montreal, Quebec, Canada.
Monica ShuklaMedical College of Wisconsin, Milwaukee, Wisconsin.
Harold Y LauTom Baker Cancer Centre, Calgary, Alberta, Canada.
Michelle MierzwaUniversity of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan.
Pedro Torres-SaavedraNRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania; American College of Radiology, Reston, Virginia.
Quynh Thu LeStanford Cancer Institute, Palo Alto, California.

Funding

NRG Oncology Network Group Operations Center - GY9 BIQSFP Reports/BudgetsU10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI NORMAN WOLMARK · 2014 to 2026
$206.8M
Statistics CoreU10CA180822 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI James J. Dignam, GREG YOTHERS · 2014 to 2026
$146.4M
IROC: Enhancing local enrolling site radiological data capture capabilities for NCTN trialsU24CA180803 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI Thomas J. FitzGerald, MICHAEL V KNOPP · 2014 to 2026
$116.2M
National Clinical Trials Network Research at the University of WisconsinUG1CA233277 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Lisa M Barroilhet, Andrew M. Baschnagel · 2019 to 2026
$4.9M
NCI NIH HHS U10 CA180822NCI NIH HHS U10 CA180868NCI NIH HHS U24 CA180803NCI NIH HHS UG1 CA233277
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Oropharyngeal NeoplasmsRadiotherapy, Intensity-ModulatedHumans

Identifiers

PMID36925074
PMCPMC10956572

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.